According to the present invention, a transparency improvement agent for the skin includes an extract from a plant that contains a rosacyanin compound.
A61K 36/31 - Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
4.
DENTAL CARE COMPOSITION AND METHOD OF PROMOTING CALCIFICATION IN LIVING BODY TISSUE
A dental care composition including an isothiocyanate having a sulfinyl group (—S(═O)—), a sulphonyl group (—S(═O)2—), a sulfide bond (—S—), or an aryl group, and an isothiocyanate group (—N═C═S). And, a composition used to promote activation of a TRPA1 channel and to promote activation of a reaction catalyzed by carbonic anhydrase.
A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A61K 8/02 - Cosmetics or similar toiletry preparations characterised by special physical form
A61Q 11/00 - Preparations for care of the teeth, of the oral cavity or of dentures, e.g. dentifrices or toothpastesMouth rinses
5.
AGENT FOR INCREASING BLOOD FLOW IN DORSOLATERAL PREFRONTAL CORTEX, AGENT FOR ACTIVATING DORSOLATERAL PREFRONTAL CORTEX, FOOD FOR INCREASING BLOOD FLOW IN DORSOLATERAL PREFRONTAL CORTEX, AND FOOD FOR ACTIVATING DORSOLATERAL PREFRONTAL CORTEX
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 36/31 - Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
6.
DENTAL CARE COMPOSITION AND METHOD FOR PROMOTING CALCIFICATION IN BIOLOGICAL TISSUES
22-), a sulfide bond (-S-), or an aryl group. A composition used for promoting activation of a reaction catalyzed by a carbonic anhydrase and activation of a TRPA1 channel.
A61Q 11/00 - Preparations for care of the teeth, of the oral cavity or of dentures, e.g. dentifrices or toothpastesMouth rinses
A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A23G 3/34 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof
A23G 4/12 - Chewing gum characterised by the composition containing microorganisms or enzymesChewing gum characterised by the composition containing paramedical or dietetical agents, e.g. vitamins
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
The present disclosure provides a neuron activator that activates neurons. The neuron activator includes at least one selected from the group consisting of a dopamine production promotor that promotes dopamine production of the neurons, a neuron extension promotor that promotes extension of the neurons, and an amyloid β resistance enhancer that enhances resistance of the neurons against amyloid β. The neuron activator includes 6-methylsulfinylhexyl isothiocyanates or glycosides thereof, and at least one selected from the group consisting of unsaturated fatty acid and polyphenol.
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A recognition function improving agent according to the present disclosure includes 6-methylsulfinylhexyl isothiocyanate. The recognition function improving agent according to the present disclosure includes a wasabi extract.
Provided is a hair restoration/growth stimulating agent containing at least one type of flavonoid represented by formula (I) as an active ingredient. Further provided is a hair restoration/growth stimulating agent containing at least one type of phenylpropanoid represented by formula (II) as an active ingredient.
A61K 8/49 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
A61Q 7/00 - Preparations for affecting hair growth
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
This recognition ability improving agent comprises 6-methylsulfinylhexyl isothiocyanate. This recognition ability improving agent comprises a Japanese horseradish extract.
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
The present disclosure provides a neuron activator that activates neurons. The neuron activator includes at least one selected from the group consisting of a dopamine production promotor that promotes dopamine production of the neurons, a neuron extension promotor that promotes extension of the neurons, and an amyloid β resistance enhancer that enhances resistance of the neurons against amyloid β. The neuron activator includes 6-methylsulfinylhexyl isothiocyanates or glycosides thereof, and at least one selected from the group consisting of unsaturated fatty acid and polyphenol.
A61K 36/16 - Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
The present disclosure relates to a method for suppressing obesity, which includes administering to a subject a compound represented by the following formula
2 is -glycosyl.
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Provided is a hair restoration/growth stimulating agent containing at least one type of flavonoid represented by formula (I) as an active ingredient. Further provided is a hair restoration/growth stimulating agent containing at least one type of phenylpropanoid represented by formula (II) as an active ingredient.
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 36/31 - Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61P 17/14 - Drugs for dermatological disorders for baldness or alopecia
A61Q 7/00 - Preparations for affecting hair growth
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
Disclosed is a composition for inhibiting allergic diseases, which is capable of inhibiting or ameliorating various symptoms of allergic diseases. Specifically disclosed is a composition for inhibiting allergic diseases, which contains an isothiocyanate and a fragrance material as active ingredients. The composition for inhibiting allergic diseases is characterized in that the isothiocyanate is composed of one or more substances selected from the group consisting of ω-methylthioalkyl isothiocyanate, ω-methylsulfinylalkyl isothiocyanate, ω-methylsulfonylalkyl isothiocyanate and ω-alkenyl isothiocyanate, and the fragrance material is composed of one or more substances selected from the group consisting of indoles, ethers, esters, ketones, fatty acids, aliphatic higher alcohols, aliphatic higher aldehydes, aliphatic higher hydrocarbons, thioethers, thiols, terpene hydrocarbons, phenol ethers, phenols, furfurals, aromatic aldehydes, aromatic alcohols, lactones, furans and natural fragrance materials.
A61K 31/4045 - Indole-alkylaminesAmides thereof, e.g. serotonin, melatonin
A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A61K 8/92 - Oils, fats or waxesDerivatives thereof, e.g. hydrogenation products
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Provided is a method for extracting isosaponarin at a high concentration from wasabi (Wasabia japonica) leaves. Also provided is a method for extracting a material for foods, drugs and cosmetics. Isosaponarin is extracted at a high concentration from wasabi leaves, said wasabi leaves being restricted to wasabi leaves having a small leaf size of, for example, 3-14 cm in the maximum leaf width in the direction perpendicular to the leaf stem and also restricted to upland-cultivated wasabi leaves, with aqueous ethanol or 1,3-butylene glycol, thereby providing foods, drugs and cosmetics containing isosaponarin at a high concentration.
Disclosed is a deodorizing agent which can deodorize unpleasant odors such as body odors, breath odors, odors of pet animals, smoke odors and food waste effectively. The deodorizing agent can be used in combination with foods, beverages, cosmetics, fragrances and the like to deodorize the odors of these products. Specifically disclosed is a deodorizing agent comprising an ω-methylthioalkylisothiocyanate such as 6-methyl- thiohexylisothiocyanate. The ω-methylthioalkylisothio- cyanate may be chemically synthesized or collected from a naturally occurring plant such as a plant belonging to the family Cruciferae, Capparaceae, Caricaceae, Resedaceae or Tropaeolaceae.
A61K 8/46 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
Disclosed is a substance which can potentiate the power of α brain waves produced from the cerebrum of a human to exhibit a relaxing activity, an concentration-enhancing activity and an anti-stress activity. Specifically disclosed is a substance having a relaxing activity, an concentration-enhancing activity and an anti-stress activity, which is characterized in that the substance comprises an isothiocyanate, and can potentiate the power of α brain waves produced from the cerebrum of a human to exhibit a relaxing activity, an concentration-enhancing activity and an anti-stress activity.
A61K 31/26 - Cyanate or isocyanate estersThiocyanate or isothiocyanate esters
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61P 25/00 - Drugs for disorders of the nervous system
A61P 39/00 - General protective or antinoxious agents
C07C 331/20 - Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
18.
COMPOSITION, FOOD, FOOD MATERIAL, PHARMACEUTICAL PREPARATION, COSMETIC AND COMMODITY EACH CONTAINING ISOTHIOCYANATE COMPOUND
Provided is a composition having an activity to promote the production and release of a calcitonin gene-related peptide (CGRP) and an activity to promote the secretion of insulin-like growth factor-1 (IGF-1). The composition can contribute to the prevention of various diseases, the improvement in QRL, the increase in beauty and the like. The composition comprises a combination of an isothiocyanate compound and at least one substance selected from a group consisting of isoflavone, raspberry ketone, capsiate, gluconic acid, chlorogenic acid, cocoa polyphenol and Haccho miso (a kind of fermented soybean paste).
A61K 31/191 - Acyclic acids having two or more hydroxy groups, e.g. gluconic acid
A61K 31/216 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K 31/222 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
patents
